227 related articles for article (PubMed ID: 20128015)
1. Pharmacoepidemiological research using French reimbursement databases: yes we can!
Martin-Latry K; Bégaud B
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):256-65. PubMed ID: 20128015
[TBL] [Abstract][Full Text] [Related]
2. [Terminology used in publications of pharmacoepidemiological research in france using health insurance reimbursement databases: need for harmonisation].
Martin-Latry K; Cougnard A
Therapie; 2010; 65(4):379-85. PubMed ID: 20854762
[TBL] [Abstract][Full Text] [Related]
3. Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study.
Noize P; Bazin F; Dufouil C; Lechevallier-Michel N; Ancelin ML; Dartigues JF; Tzourio C; Moore N; Fourrier-Réglat A
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):310-9. PubMed ID: 19241438
[TBL] [Abstract][Full Text] [Related]
4. A cohort study of therapeutic prescriptions after the end of phytotherapy drug reimbursement by French Social Security.
Riou França L; Vidal C; Bourechak N; Jeunne PL; Deville GS; Massol J
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):760-8. PubMed ID: 23208799
[TBL] [Abstract][Full Text] [Related]
5. Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database.
Liou WS; Hsieh SC; Chang WY; Wu GH; Huang HS; Lee C
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):752-9. PubMed ID: 23625864
[TBL] [Abstract][Full Text] [Related]
6. The Nordic countries as a cohort for pharmacoepidemiological research.
Furu K; Wettermark B; Andersen M; Martikainen JE; Almarsdottir AB; Sørensen HT
Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):86-94. PubMed ID: 19961477
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoepidemiology--an Irish perspective.
Williams D; Feely J
Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):641-5. PubMed ID: 11980254
[TBL] [Abstract][Full Text] [Related]
8. Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies.
Palmaro A; Moulis G; Despas F; Dupouy J; Lapeyre-Mestre M
Fundam Clin Pharmacol; 2016 Dec; 30(6):616-624. PubMed ID: 27351637
[TBL] [Abstract][Full Text] [Related]
9. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
[TBL] [Abstract][Full Text] [Related]
10. The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database.
Hsieh SC; Lai JN; Lee CF; Hu FC; Tseng WL; Wang JD
Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):609-19. PubMed ID: 18481335
[TBL] [Abstract][Full Text] [Related]
11. How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database.
Latry P; Molimard M; Bégaud B; Martin-Latry K
Eur J Clin Pharmacol; 2010 Jul; 66(7):743-8. PubMed ID: 20429000
[TBL] [Abstract][Full Text] [Related]
12. Concordance between prescriber- and patient-reported previous medical history and NSAID indication in the CADEUS cohort.
Fourrier-Réglat A; Cuong HM; Lassalle R; Depont F; Robinson P; Droz-Perroteau C; Pariente A; Bégaud B; Blin P; Moore N
Pharmacoepidemiol Drug Saf; 2010 May; 19(5):474-81. PubMed ID: 20437457
[TBL] [Abstract][Full Text] [Related]
13. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
14. Databases for pediatric medicine research in Europe--assessment and critical appraisal.
Neubert A; Sturkenboom MC; Murray ML; Verhamme KM; Nicolosi A; Giaquinto C; Ceci A; Wong IC;
Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1155-67. PubMed ID: 18979461
[TBL] [Abstract][Full Text] [Related]
15. Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies.
Becher H; Kostev K; Schröder-Bernhardi D
Int J Clin Pharmacol Ther; 2009 Oct; 47(10):617-26. PubMed ID: 19825325
[TBL] [Abstract][Full Text] [Related]
16. Record linkage for pharmacoepidemiological studies in cancer patients.
Herk-Sukel MP; Lemmens VE; Poll-Franse LV; Herings RM; Coebergh JW
Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):94-103. PubMed ID: 21812067
[TBL] [Abstract][Full Text] [Related]
17. Impact of prescriber nonresponse on patient representativeness.
Fourrier-Réglat A; Droz-Perroteau C; Bénichou J; Depont F; Amouretti M; Bégaud B; Moride Y; Blin P; Moore N;
Epidemiology; 2008 Mar; 19(2):186-90. PubMed ID: 18300697
[TBL] [Abstract][Full Text] [Related]
18. Effects of an evidence report and policies lifting reimbursement restrictions for acid suppressants: analysis of the Belgian national database.
van Driel ML; Vander Stichele R; Elseviers M; De Sutter A; De Maeseneer J; Christiaens T
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1113-22. PubMed ID: 18823069
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.
Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C
Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the variability in drug-prescribing patterns: benchmarking and feedback in Belgium.
Delesie L; Croes L
Eur J Clin Pharmacol; 2002 Jun; 58(3):215-21. PubMed ID: 12107608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
